[ad_1]
Biotechnology agency Biogen Inc. (NASDAQ: BIIB) reported decrease earnings, on an adjusted foundation, and revenues for the primary quarter of 2023.
Whole income declined 3% year-over-year to $2.46 billion. For the complete 12 months of 2023, the corporate expects revenues to say no within the mid-single digit proportion and tasks adjusted earnings per share within the vary of $15.00 to 16.00.
Internet earnings attributable to Biogen Inc. was $387.9 million or $2.67 per share in Q1, in comparison with $303.8 million or $2.06 per share final 12 months. Adjusted earnings declined 6% to $3.40 per share.
Prior Efficiency
[ad_2]
Source link
